Supplemental MRI May Save More Lives in High-Risk Women
Adding biennial magnetic resonance imaging (MRI) to routine mammographic screening could avert more breast cancer deaths among women with extremely dense breasts and higher-than-average cancer risk. The finding comes from a collaborative modeling study published in the Annals of Internal Medicine, funded by the National Cancer Institute, which compared scenarios combining digital breast tomosynthesis (3D mammography) with supplemental MRI.
Study Methodology and Results
Researchers used Breast Cancer Surveillance Consortium (BCSC) data with three Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer simulation models to compare clinical and economic outcomes. They evaluated digital breast tomosynthesis alone versus tomosynthesis combined with MRI for women aged 40 and over at average to four times higher breast cancer risk levels.
Results showed that mammography alone prevented the majority of breast cancer deaths. Adding MRI provided modest additional benefit but also led to more false-positive biopsy recommendations. When MRI was added specifically for women with extremely dense breasts and at least double the average cancer risk, the balance of benefits and harms was comparable to conventional mammographic screening.
New Density Notification Regulations
The study gains relevance amid changing regulatory landscape. In the United States, new federally mandated breast density notification regulations now require mammography facilities to inform patients about their breast density. This change has generated demand for clear guidance on when supplemental exams are truly beneficial.
Breast density is classified into four categories (A through D) under the BI-RADS system. Women in category D (extremely dense breasts) represent approximately 10% of the female population and face significantly higher risk of both breast cancer and false-negative results on conventional mammography. In this subgroup, MRI offers superior diagnostic capability thanks to its soft tissue contrast.
Cost-Benefit Balance and False Positives
A crucial aspect of the study is acknowledging that supplemental MRI, while effective at detection, also increases unnecessary biopsy rates. Researchers concluded that supplemental MRI could be a reasonable option for higher-risk women with dense breasts, “especially if MRI costs and unnecessary biopsies can be reduced.”
The evolving technology in breast imaging exams and the development of abbreviated MRI protocols may help make this modality more accessible and economically viable for broader populations.
Clinical Implications and Future Perspectives
For radiologists and breast specialists, the study provides evidence supporting a stratified approach: not every woman with dense breasts needs supplemental MRI, but those with elevated risk combined with extreme density may benefit significantly. Integrating AI tools into the mammographic workflow can facilitate identifying these patients and optimizing referrals for MRI.
Combined with recent advances in AI for cancer screening, these data point toward a future where breast cancer screening becomes increasingly personalized, with protocols adapted to each woman’s individual risk profile rather than a one-size-fits-all approach.
Source: ITN Online